BioWorld MedTech

Nov. 15, 2016

Wearable med tech arrives at a plateau in Asian market as barriers to use increase

SINGAPORE – The wearable med-tech space saw a heated flurry of activity over the last year across Asia, but enthusiasm has cooled considerably as the obstacles that lie ahead for the sector become more apparent. Read More

Wearable ultrasound glasses help give clinicians 'Eyes-On' vasculature roadmap

Siemens announces spin out of its Healthineers health care unit for IPO

Integragen to launch predictive biomarkers

Appointments and advancements

Daily M&A

Product briefs

Other news to note

MDD's Cardiology Extra

Today's news in brief

BioWorld

BioWorld briefs for Dec. 24, 2025.

Today's news in brief

BioWorld MedTech

BioWorld MedTech briefs for Dec. 24, 2025.

Illustration of magnifying glass looking at cancer in the brain

Researchers discover how glioblastoma tumors dodge chemotherapy

BioWorld MedTech

Researchers at the University of Sydney have uncovered a mechanism that may explain why glioblastoma returns after treatment, and the world-first discovery offers...

Left: Anthony Fauci. Right: Transmission electron micrograph of HIV-1 virus particles

HIV research is close to a cure but far from ending the pandemic

BioWorld

Advances in antiretroviral therapy (ART) now allow people living with HIV to lead normal lives with undetectable and nontransmissible levels of the virus in their...

Apollo’s APL-4098 shows potent antileukemic effects

BioWorld Science

Apollo Therapeutics Ltd. has developed APL-4098, a small-molecule general control nonderepressible 2 (GCN2) inhibitor for the potential treatment of AML.